Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)

OBJECTIVE: Increases in serum calcitonin, a tumor marker for medullary thyroid carcinoma (MTC), have been associated with glucagon-like peptide 1 receptor agonist use in some preclinical studies. We report calcitonin changes in exenatide-treated and placebo-administered participants and MTC incidenc...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Diabetes Care
Glavni autori: Bethel, M. Angelyn, Patel, Rishi A., Thompson, Vivian P., Merrill, Peter, Reed, Shelby D., Li, Yanhong, Ahmadi, Sara, Katona, Brian G., Gustavson, Stephanie M., Ohman, Peter, Iqbal, Nayyar, Gagel, Robert F., Hernandez, Adrian F., Buse, John B., Holman, Rury R.
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2019
Teme:
Emerging Therapies: Drugs and Regimens
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6973544/
https://ncbi.nlm.nih.gov/pubmed/31010875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc18-2028
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items